Status:
COMPLETED
Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study)
Lead Sponsor:
Ain Shams University
Conditions:
Stroke, Ischemic
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
Cerebral Endovascular Stenting of medically refractory Intracranial Stenotic Blood Vessels with Recurrent Ischemic Strokes patients
Detailed Description
Fifty patients were enrolled with 25 underwent Intracranial Stenting 25 received optimal medicall treatment without stenting and comparative study of primary outcome was conducted
Eligibility Criteria
Inclusion
- Patients age between 30-80 years.
- Symptomatic ICAS: presented with TIA or stroke, attributed to 70%-99% stenosis of a major intracranial artery: Internal carotid artery (ICA), middle cerebral artery (MCA) \[M1segment\], vertebral artery (VA), or basilar artery (BA).
- Patient with recurrent TIA or stroke despite medical therapy, including anti-coagulation or antiplatelet and control of all vascular risk factors (DM, HTN and Hyperlipidemia).
Exclusion
- Patients previously stented at the target lesion or had extracranial stenosis.
- Patient with acute stroke (within two weeks from the onset).
- Complete occlusion of the artery on the imaging assessment.
- Massive cerebral infarction (more than half the MCA territory), intracranial hemorrhage, epidural or subdural hemorrhage, and intracranial brain tumor on CT or MRI scans.
- Contraindications to antithrombotic and/or anticoagulant therapies.
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04393025
Start Date
June 1 2016
End Date
June 1 2019
Last Update
May 19 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.